Key facts
- China's biopharma industry is emerging as a global leader.
- The sector is characterized by rapid innovation and strategic investments.
- China's biopharma sector is expected to significantly impact the global industry.
China's biopharmaceutical industry is rapidly expanding its global influence, driven by innovation and strategic investments. The sector is expected to play a significant role in shaping the future of global healthcare. McKinsey & Company's 'Vision 2028' report highlights China's potential impact on the global biopharma landscape, suggesting a trajectory of increasing importance and competitiveness for Chinese companies in the international market.